Syrosingopine | CAS:84-36-6 | Manufacturer ChemFaces

Syrosingopine

ChemFaces products have been cited in many studies from excellent and top scientific journals

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / Inquiry
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Myrrhone

Catalog No: CFN91042
CAS No: 183551-83-9
Price: $388/5mg

Plantamajoside

Catalog No: CFN99522
CAS No: 104777-68-6
Price: $100/20mg

Isovitexin

Catalog No: CFN98620
CAS No: 38953-85-4
Price: $50/20mg

Alisol C

Catalog No: CFN92545
CAS No: 30489-27-1
Price: $318/5mg

Squalene

Catalog No: CFN99208
CAS No: 111-02-4
Price: $30/20mg

Pulegone

Catalog No: CFN93286
CAS No: 89-82-7
Price: $30/20mg

Glycycoumarin

Catalog No: CFN89408
CAS No: 94805-82-0
Price: $268/10mg

Soyasaponin Ac

Catalog No: CFN90774
CAS No: 133882-74-3
Price: $ / mg

7-Epitaxol

Catalog No: CFN90371
CAS No: 105454-04-4
Price: $60/20mg

Praeruptorin B

Catalog No: CFN98140
CAS No: 81740-07-0
Price: $148/10mg

Description:

Syrosingopine has selective depleting effect on brain amines is potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor. Syrosingopine can sensitize cancer cells to metformin and its more potent derivative phenformin far below the individual toxic threshold of each compound, thus, combining syrosingopine and codrugs is a promising therapeutic strategy for clinical application for the treatment of cancer.Syrosingopine also has hypotensive properties.

Targets:

In vitro:

Sci. Adv.,2016 Dec; 2(12): e1601756.

Syrosingopine sensitizes cancer cells to killing by metformin[Pubmed: 28028542]

METHODS AND RESULTS:
We report that the anticancer activity of the widely used diabetic drug metformin is strongly potentiated by Syrosingopine. Synthetic lethality elicited by combining the two drugs is synergistic and specific to transformed cells. This effect is unrelated to Syrosingopine’s known role as an inhibitor of the vesicular monoamine transporters. Syrosingopine binds to the glycolytic enzyme α-enolase in vitro, and the expression of the γ-enolase isoform correlates with nonresponsiveness to the drug combination. Syrosingopine sensitized cancer cells to metformin and its more potent derivative phenformin far below the individual toxic threshold of each compound.
CONCLUSIONS:
Thus, combining Syrosingopine and codrugs is a promising therapeutic strategy for clinical application for the treatment of cancer.

C R Seances Soc Biol Fil. 1960;154:55-7.

Hypertensive action of syrosingopine after ephedrine.[Pubmed: 14443141]

METHODS AND RESULTS:
Hypertensive action of Syrosingopine after ephedrine.

In vivo:

Pharmacol Biochem Behav. 1986 May;24(5):1457-9.

Effects of amnesic doses of reserpine or syrosingopine on mouse brain acetylcholine levels.[Pubmed: 2873591]

The effects of reserpine and Syrosingopine on mouse whole brain acetylcholine levels were examined.
METHODS AND RESULTS:
At 2 or 24 hr following injection, the brains were removed and analyzed by mass spectrometry. No differences were found between drug-treated and control mice in the acetylcholine content of the brain at either time interval.
CONCLUSIONS:
The results suggest that whole brain acetylcholine levels do not predict the amnesic effects of either reserpine or Syrosingopine.

Behav Neural Biol. 1983 May;38(1):120-6.

The effect of reserpine, syrosingopine, and guanethidine on the retention of discriminated escape reversal: peripherally administered catecholamines cannot reverse the reserpine amnesia in this situation.[Pubmed: 6138025]

METHODS AND RESULTS:
In a series of experiments, the effects of reserpine, Syrosingopine, and guanethidine on retention of a discriminated escape reversal training were investigated in mice. The peripherally and centrally acting reserpine produced amnesia while the primarily peripherally acting compounds, Syrosingopine or guanethidine, did not produce amnesia even when given in high dosages or when training was given with low footshock.
CONCLUSIONS:
Unlike in the passive avoidance situation, peripherally administered norepinephrine or dopamine was not able to attenuate the reserpine-induced amnesia. The results were discussed in terms of the role of biogenic amines in memory formation.

Syrosingopine Description

Source:	The roots of Rauvolfia yunnanensis Tsiang
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Animal Research:

Pharmacol Biochem Behav. 1976 Apr;4(4):419-25.

Selective depleting effect of syrosingopine on brain catecholamine levels with relation to morphine analgesia in the rat.[Pubmed: 6976 ]

Reserpine was the most potent, rescinnamine the next and Syrosingopine the weakest in the depleting effects on brain amines of rauwolfia alkaloids.
METHODS AND RESULTS:
After Syrosingopine, brain dopamine (DA) was decreased to a smaller degree and with a shorter duration as compared with norepinephrine (NE) and serotonin (5-HT), whereas reserpine elicited a marked and long lasting reduction in these amines. Accordingly, Syrosingopine induced a depletion of brain NE and 5-HT without alteration in brain DA content 2-4 days after administration. Repeated administrations of Syrosingopine, 2 mg/kg daily for 2 or 4 days, resulted in similar alterations in brain amine levels. This selective depleting effect of Syrosingopine on brain amines was potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor. Under the condition of selective depletion of brain amines induced by repeated administrations of Syrosingopine, 2 mg/kg daily for 2 days, the analgesic action of morphine was not affected, whereas reserpine and tetrabenazine antagonized morphine analgesia, concomitant with inducing a depletion of all brain amines.
CONCLUSIONS:
The results suggest that brain DA may be more important than brain NE or 5-HT with regard to the mechanisms by which morpine produces analgesia.

Product Name	Syrosingopine
Price:
CAS No.:	84-36-6
Catalog No.:	CFN98542
Molecular Formula:	C₃₅H₄₂N₂O₁₁
Molecular Weight:	666.71 g/mol
Purity:	>=98%
Type of Compound:	Alkaloids
Physical Desc.:	Powder
Source:	The roots of Rauvolfia yunnanensis Tsiang
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Download:	COA MSDS SDF Manual
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Antihypertensive Compound Library Sensitizers Compound Library Alkaloids Compound Library NF-kB Inhibitor Library Mdm2 Inhibitor Library Histone Methyltransferase Inhibitor Library HCV Inhibitor Library Antifection Inhibitor Library Androgen Receptor Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	1.4999 mL	7.4995 mL	14.999 mL	29.9981 mL	37.4976 mL
5 mM	0.3 mL	1.4999 mL	2.9998 mL	5.9996 mL	7.4995 mL
10 mM	0.15 mL	0.75 mL	1.4999 mL	2.9998 mL	3.7498 mL
50 mM	0.03 mL	0.15 mL	0.3 mL	0.6 mL	0.75 mL
100 mM	0.015 mL	0.075 mL	0.15 mL	0.3 mL	0.375 mL

CFN92577	Allo-Yohimbine	522-94-1	354.5	C₂₁H₂₆N₂O₃
CFN92579	Methyl reserpate	2901-66-8	414.5	C₂₃H₃₀N₂O₅
CFN92580	Reserpinine	24815-24-5	634.7	C₃₅H₄₂N₂O₉
CFN92583	Reserpin N-oxide	474-48-6	624.7	C₃₃H₄₀N₂O₁₀
CFN92610	18-Beta-hydroxy-3-epi-alpha-yohimbine	81703-06-2	370.5	C₂₁H₂₆N₂O₄
CFN98112	Reserpine	50-55-5	608.69	C₃₃H₄₀N₂O₉
CFN98542	Syrosingopine	84-36-6	666.71	C₃₅H₄₂N₂O₁₁
CFN98762	Isorauhimbine	483-09-0	354.5	C₂₁H₂₆N₂O₃
CFN98921	beta-Yohimbine	549-84-8	354.5	C₂₁H₂₆N₂O₃
CFN99400	alpha-Yohimbine	131-03-3	354.5	C₂₁H₂₆N₂O₃